It is indeed highly improbable that single agent chemotherapy alone will cure a tumour consisting of > 107 malignant cells. Combining two or more (active) drugs, is one way to circumvene this problem of drug resistance. In mesothelioma, the choice of combination is often empirical, sometimes ...
Mesothelioma is classified by where it starts in the body. The location of a tumor can play a role in determining what type of surgery options, if any, are available to you. Unfortunately, with all types of mesothelioma, by the time you consider surgery, the tumors often have spread too ...
"Inflammation is key to the development of pleural mesothelioma and, as such, it represents a key target for immunotherapy. This, in addition to earlier studies that showed promising results using the same immunotherapy drug in previously treated cases, led us to study the combination," says For...
Treatment of malignant mesothelioma with epirubicin and ifosfamide: a phase II cooperative study. Ann Oncol 1992;3:237-238.Magri MD, Veronesi A, Foladore S, et al. Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North- Eastern Italian Oncology Group (...
215TiP STELLAR – A phase II trial of TTFields with chemotherapy for first line treatment of malignant mesothelioma Therapeutic options for malignant pleural mesothelioma (MPM) are limited. Most patients are treated with chemotherapy during the course of their disease. The combination of pemetrexed with...
MESOTHELIOMA IN ·SOUTH AFRICA Objectives. To describe the exposure experiences of South African mesothelioma cases, with emphasis on the contribution made to the caseload by different f... D Rees,K Goodman,E Fourie,... 被引量: 0发表: 2008年 Malignant mesothelioma with intracytoplasmic crystalline...
of development of novel tumor therapeutics and the development of immunotherapeutic drugs has also exhibited explosive growth (3-5). The 2019 anti-cancer progress report released by the American Association for Cancer Research (6) listed cancer immunotherapy with surgery, chemotherapy, radiotherapy and ...
Mesothelioma is a deadly cancer that affects the smooth, protective tissue covering the lungs, abdomen, heart and testes. The primary cause of mesothelioma is exposure to asbestos fibers and dust, usually through occupational exposure. Doctors treat mesothelioma with surgery, chemotherapy, immunotherapy...
Paul Sugarbaker, innovated the most effective procedure for peritoneal mesothelioma there. It combines cytoreductive surgery with heated chemotherapy. Sugarbaker has retired, but surgeons that trained with him continue his legacy. blog Flores: State of Cancer in 9/11 First Responders and Survivors ...
Mesothelioma is a rare type of cancer that is strongly tied to asbestos exposure. Despite application of different modalities such as chemotherapy, radiotherapy and surgery, patient prognosis remains very poor and therapies are ineffective. Much research currently focuses on the application of novel appr...